BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld
Home
» Other news to note for March 23, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for March 23, 2020
March 23, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, AC Immune, Allovir, Amneal, Aptevo, Astrazeneca, Bellus, Boehringer, Celltrion, Cel-Sci, CNS, Codexis, Eli Lilly, E-therapeutics, Etherna, Medexus, Merck, Moleculin, Neoimmunetech, Novan, Pharnext, Resverlogix, Schrodinger, Smartpharm, Soligenix, Sorrento, Syncona, Takeda, Tetra, Ubix, WPD, Zealand, Ziphius.
BioWorld
Briefs
Other news to note
Coronavirus